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Leptin causes vasodilatation both by endothelium-dependent and -independent mecha-
nisms. Leptin is synthesized by perivascular adipose tissue (PVAT). The hypothesis of this
study is that a decrease of leptin production in PVAT of spontaneously hypertensive rats
(SHR) might contribute to a diminished paracrine anticontractile effect of the hormone.We
have determined in aorta from Wistar-Kyoto (WKY) and SHR (i) leptin mRNA and protein
levels in PVAT, (ii) the effect of leptin and PVAT on contractile responses, and (iii) leptin-
induced relaxation and nitric oxide (NO) production. Leptin mRNA and protein expression
were signiﬁcantly lower in PVAT from SHR. Concentration-response curves to angiotensin
II were signiﬁcantly blunted in presence of PVAT as well as by exogenous leptin (10−9 M)
only inWKY.This anticontractile effect was endothelium-dependent.Vasodilatation induced
by leptin was smaller in SHR than in WKY, and was also endothelium-dependent. More-
over, release of endothelial NO in response to acute leptin was higher inWKY compared to
SHR, but completely abolished in the absence of endothelium. In conclusion, the reduced
anticontractile effect of PVAT in SHR might be attributed to a reduced PVAT-derived leptin
and to an abrogated effect of leptin on endothelial NO release probably due to an impaired
activation of endothelial NO synthase.
Keywords: perivascular adipose tissue, hypertension, angiotensin II, leptin, nitric oxide
INTRODUCTION
Perivascular adipose tissue (PVAT) is now considered a highly
active endocrine organ that releases a variety of adipokines,
inﬂammatory cytokines, and other factors which inﬂuence vas-
cular tone in a paracrine way (Gollasch and Dubrovska, 2004;
Gao, 2007). PVAT releases a number of vasodilatory factors, such
as adipocyte-derived relaxing factor (ADRF; Löhn et al., 2002;
Dubrovska et al., 2004; Verlohren et al., 2004; Gálvez et al., 2006),
leptin (Payne et al., 2010; Dashwood et al., 2011), adiponectin
(Fesüs et al., 2007), angiotensin 1–7 (Ang 1-7; Lee et al., 2009),
hydrogen peroxide (Gao et al., 2007), and nitric oxide (NO; Gil-
Ortega et al., 2010). Moreover, PVAT also releases vasoconstrictor
factors such as angiotensin II (Ang II; Gálvez-Prieto et al., 2008)
and superoxide anion (Gao et al., 2006). Under physiological
conditions, PVAT elicits a net anticontractile beneﬁcial effect on
vascular function that is essential for the maintenance of vascular
resistance. In presence of PVAT, arteries and veins from different
species, including human, exhibit lower contractions to a variety
of vasoconstrictors than arteries cleaned of PVAT.
Perivascular adipose tissue undergoes structural and func-
tional changes in pathophysiological conditions. During early
diet-induced obesity (DIO) an adaptative NO overproduction
occurs in PVAT, probably aimed at protecting vascular function
(Gil-Ortega et al., 2010). However, in established obesity, PVAT
looses its anticontractile properties (Gao et al., 2005) by an increase
of oxidative stress that leads to endothelial dysfunction (Gil-
Ortega et al., 2009). In spontaneously hypertensive rats (SHR),
a lean model of hypertension, mesenteric adipose pads are lighter
compared to normotensive Wistar-Kyoto rats (WKY; Gálvez et al.,
2006). Accordingly, plasma and mesenteric leptin content are also
reduced in this strain. The lower amount of adipose tissue (AT)
facilitates contraction in mesenteric arteries, likely attributable to
a diminished paracrine regulation of perivascular fat on mesen-
teric arterial tone via Kv channels (Gálvez et al., 2006). Moreover,
periaorticAT fromSHRalso shows a reduced anticontractile effect,
probably related to the increase in the number of brown adipocytes
and to a reduction in the production of Ang 1–7 (Lu et al., 2011).
Leptin is a lipostatic hormone synthesized mainly by white AT
(Zhang et al., 1994) and to a minor extent by brown adipocytes
(Cannon and Nedergaard, 2004). Leptin monitors the status of
energy reserves being more secreted the larger the adipocytes
are. Consequently, plasma leptin concentration correlates with the
amount of AT (Schwartz et al., 1996; Somoza et al., 2007). Lep-
tin also participates in the regulation of vascular tone, although
mechanisms are still unclear and contradictory (for review, see
Knudson et al., 2008). Vascular effects of leptin seem to be the
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net result of two different actions: (i) indirect vasoconstriction
through stimulation of sympathetic activity at hypothalamic level
(Elias et al., 1998; Hall et al., 2000) and (ii) direct vasodilation,
that depends on an intact and functional endothelium, through
mechanisms that vary between different vascular beds and species.
In vivo experiments in rats have revealed that leptin infusion
reduces arterial pressure by increasing NO (Frühbeck, 1999). In
isolated aorta, vasodilation involves NO release (Sahin et al., 2009)
through a mechanism linked to the activation of endothelial NO
synthase (eNOS) via Akt-dependent phosphorylation of eNOS
at Ser1177 (Lembo et al., 2000; Vecchione et al., 2002). In rat
mesenteric arteries, leptin induces the release of endothelium-
derived hyperpolarizing factor (Lembo et al., 2000). Moreover,
an endothelium-independent anticontractile effect of leptin on
Ang II-induced contractions has been described. In humans, lep-
tin induces vasodilation in saphenous vein and internal mammary
artery through an endothelium-independent mechanism (Momin
et al., 2006). Abrogated vasodilatory and antiproliferative effects
of leptin have been reported in blood vessels from SHR (For-
tuño et al., 2002; Rodriguez et al., 2007; Rodríguez et al., 2010),
contributing to an increase in vascular contractions.
The hypothesis of the current study is that the decrease of
anticontractile effect of PVAT observed in SHR deals with a down-
regulation of leptin production within this tissue. Our aim was to
characterize in both SHR and WKY aorta (i) leptin expression
and protein in PVAT, (ii) the vasodilatory effect and NO produc-
tion elicited by leptin, and (iii) the effect of leptin and PVAT on
contractile responses.
MATERIALS AND METHODS
ANIMALS
Experiments were conducted in 3-month-old maleWKY and SHR
(250–300 g; Charles River, Barcelona, Spain) maintained under
controlled light (12 h light cycles from 8.00 to 20.00 hours) and
temperature (22–24˚C) conditions. Rats were fed a normal rat
chow (A.04, Panlab, Barcelona, Spain) and had free access to tap
water. Systolic bloodpressurewasmonitoredunder sodiumpento-
barbital anesthesia (50mg/kg; i.p.) in a group of SHR as previously
described (Gálvez et al., 2006). The Institutional Animal Care and
Use Committee approved all experimental procedures according
to the guidelines for ethical care of experimental animals of the
European Community.
For sampling and functional measures animals (n = 16 per
strain)were killed by decapitation.We avoided 24 h fasting because
fasting stimulates lipid mobilization and lipolysis and decreases
plasma leptin concentration (Cano et al., 2003). Therefore,we per-
formed plasma extraction in the morning, thus plasma values cor-
responding to postprandial concentrations. Blood was collected in
EDTA-coated tubes, and plasma preserved after centrifugation at
−20˚C until biochemical assays. The aorta was quickly dissected
and preserved in oxygenated Krebs solution until used for func-
tional or confocal microscopy studies. Periaortic AT was frozen at
−80˚C for determination of leptin expression and protein levels.
RNA ISOLATION, REVERSE TRANSCRIPTION, AND QUANTITATIVE
REAL-TIME PCR FOR LEPTIN EXPRESSION
Total RNA of AT was isolated using RNeasy® Lipid Tissue Mini
Kit (Qiagen, Hilden, Germany) according to the manufactures
protocol. An on-column DNase digestion step was included in
the protocol with RNase-Free DNase Set (Qiagen, Hilden, Ger-
many) to minimize genomic contamination. Concentration and
purity of isolated RNA was determined by measuring the extinc-
tion at 260 and 280 nm. One microgram total RNA was reverse
transcribed in 40μl ﬁnal volume using First Strand cDNA Syn-
thesis Kit (Fermentas GmbH, St. Leon-Rot, Germany) according
to the manufacturer’s instructions. Transcribed cDNA was stored
at −20˚C until further use.
To quantify expression levels of leptin we employed the real-
time quantitative RT (“TaqMan”) PCR. Brieﬂy, the ABI PRISM
7000 SDS instrument in conjunction with the ABI TaqMan Uni-
versal Master Mix (Applied Biosystems, Darmstadt, Germany)
was used to perform the assays with a ﬁnal concentration of
300 nM for the primers and 100 nM for the probes. Fluorogenic
probes and primers were synthesized by TIB Molbiol (Berlin,
Germany). Sense, antisense primer and probe sequences for
leptin were the following, respectively: 5′-AACCCTCATCAAGA
CCATTGTCA-3′, 5′-GGTCCATCTTGGACAAACTCAGA-3′, 5′-
CTTCATTCCCGGGCTTCACCCC-3′. To avoid signals of
genomic origin intron spanning primers were used and primers
were checked for genomic signal before use. Speciﬁcity of the prod-
uctwas conﬁrmedby sequencing. Relative quantiﬁcationwas done
using the standard curve method. Every sample was measured
in triplicate. To normalize our expression data we used 18S as a
housekeeping gene.
WESTERN BLOT OF LEPTIN Ob-R RECEPTORS
Ob-Rb proteins were measured in aorta from SHR and WKY.
Brieﬂy, tissues were homogenized in ice-cold buffer containing
0.42M NaCl, 20mM HEPES (pH 7.9), 1mM Na4P2O7, 1mM
EDTA, 1mM EGTA, 1mM dithiothreitol, 20% glycerol, 1μg/ml
aprotinin, 1μg/ml leupeptin, 20mM sodium ﬂuoride, 1mM
trisodium orthovanadate, and 2mM phenylmethylsulfonyl ﬂuo-
ride. Tubes containing homogenates were frozen at −80˚C and
thawed at 37˚C three consecutive times, then centrifuged for
10min at 4˚C. Equivalent amounts of proteins (50 μg) present
in the supernatant were loaded in Laemmli buffer (50mM Tris
pH= 6.8, 10% SDS, 10% glycerol, 5% mercaptoethanol, and
2mg/ml blue bromophenol) and size-separated in 15% SDS-
polyacrylamide gel electrophoresis. Proteins were transferred to
PVDF membranes (Amersham Pharmacia, Spain) using a trans-
blot apparatus (Bio-Rad, Spain). For immunoblotting, mem-
branes were blocked with 5% non-fat dried milk in Tween-PBS
(TPBS) for 1 h. Primary antibodies against pSTAT3 (Tyr705; Cell
Signaling Technology, USA; 1/100 ﬁnal dilution), STAT3 (Santa
Cruz Biotechnology, USA; 1/1000 ﬁnal dilution), or leptin recep-
tor (Afﬁnity Bioreagents, USA, 1/2000 ﬁnal dilution) were applied
overnight at 4˚C. After washing, appropriate secondary antibod-
ies (anti-goat IgG-peroxidase conjugated) were applied for 1 h
at a dilution of 1/10000. Blots were washed, incubated in com-
mercial enhanced chemiluminescence reagents (ECL, Amersham
Bioscience, UK) and exposed to autoradiographic ﬁlm. To prove
equal loadings of samples, blots were re-incubated with β-actin
antibody (Afﬁnity Bioreagents, USA). Films were scanned using a
GS-800 Calibrated Densitometer (Bio-Rad, Spain) and blots were
quantiﬁed using Quantity One software (Bio-Rad, Spain). Values
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for Ob-Rb were normalized with β-actin to account for variations
in gel loading.
LEPTIN ASSAY
Leptin concentration in plasma and periaortic AT was analyzed by
using a speciﬁc enzyme immunoassay (ELISA) kit for rat leptin
(Assay Designs Inc., USA) as previously described (Gálvez et al.,
2006). Intra-assay and inter-assay variations were 11.6 and 11%,
respectively.
FUNCTIONAL STUDIES
The aorta was carefully isolated, placed in oxygenated physio-
logical salt solution (PSS), and cleaned of blood and perivas-
cular fat. PSS had the following composition: 115mM NaCl,
4.6mM KCl, 2.5mM CaCl2, 25mM NaHCO3, 1.2mM KH2PO4,
1.2mM MgSO4, 0.01mM EDTA, and 5.5mM glucose. All
experiments were performed in presence of dexamethasone
(0.8μM) and indomethacin (5μM) to avoid iNOS induction
and prostaglandin-mediated effects, respectively. Preincubation
with these drugs did not modify the anticontractile effect of
PVAT. After an equilibration period of 90min and before start-
ing the experiment, aortic rings were contracted with KCl 75mM
to assess their contractility. Subsequently, segments were con-
tractedwith phenylephrine (10−7 M) and acetylcholine (Ach,10−9
to 10−4 M) was added to functionally conﬁrm the presence of
the endothelium. Rat leptin (Sigma, USA) was tested between
10−10 and 10−8 M in vessels preconstricted with U46619 (10−7 M;
Sigma, USA). In order to conﬁrm that leptin vasodilation is
endothelium-dependent, a set of experiments was carried out in
endothelium-denuded segments.
DETERMINATION BY CONFOCAL MICROSCOPY OF NO AVAILABILITY
AFTER LEPTIN STIMULATION
Nitric oxide availability was determined by the ﬂuorescent NO
indicator 4,5-diaminoﬂuorescein diacetate (DAF-2, Sigma) as pre-
viously described (Somoza et al., 2005; Arribas et al., 2007). Intact
and endothelium-denuded aortas were cut in 3mm segments
and stabilized in PSS containing 0.8μM dexamethasone (to avoid
iNOS induction) and 15U/ml SOD (to avoid NO inactivation by
superoxide anions) for 30min at 37˚C. Thereafter, the segments
were stained with 10−5 M DAF-2 dissolved in PSS and incubated
in the darkness at room temperature in a shaking bath for 30min
in the presence or absence of leptin (10 ng/ml). Some segments
were incubated with Ach (10−6 M, positive controls) or 10−4 M
L-NAME (Nω-nitro-l-arginine methyl ester; negative controls)
throughout the experimental period. Following the 30min DAF-2
incubation period, the arterial segments were cut in 50 μm thick
rings, washed in PSS and mounted on slides for visualization with
a Leica TCS SP2 confocal system (Leica Microsystems, Germany)
ﬁtted with argon and helio-neon laser sources and coupled to
a Leica DMIRE 2 microscope, using the 488/515 nm line of the
microscope. Stacks of 15 serial optical sections (1 μm thick) were
captured fromeach ringwith a 20×objective,2× zoomand amax-
imal projection was then obtained. All images from control and
stimulated rings were captured under identical conditions of laser
intensity, brightness, and contrast. From these images, reconstruc-
tions were obtained and quantiﬁcation of ﬂuorescence intensity
into nuclei was determined by using Image-J (N.I.H. USA).
STATISTICAL ANALYSIS
All values are given as mean± SEM. Student’s t tests or ANOVA
were used as appropriate. A value of p< 0.05 was considered
statistically signiﬁcant.
RESULTS
CHARACTERIZATION OF ANIMALS
Spontaneously hypertensive rats exhibited signiﬁcantly elevated
systolic and diastolic blood pressures than WKY (179± 8 and
136± 6mm Hg vs. 131± 4 and 95± 6mm Hg, respectively;
p< 0.05). Moreover, there was no signiﬁcant difference in body
weight between WKY and SHR (400 ± 8 vs. 404± 10 g).
As summarized in Table 1, lumbar and mesenteric pads were
lighter in SHR than in WKY (p< 0.05). Periaortic AT amount
was, however, similar between both strains. Plasma leptin con-
centration in WKY (11.5± 2.2 ng/ml) and SHR (7.6± 1.0 ng/ml;
p< 0.05) exhibited a positive correlation with the total amount
of AT (r = 0.84; p< 0.05). Other metabolic features of WKY and
SHR have been analyzed in a previous study (Gálvez et al., 2006).
THE ANTICONTRACTILE EFFECT OF PVAT IS REDUCED IN SHR
Concentration-response curves to Ang II were compared in
presence and in absence of PVAT. To exclude participation of
periaortic-derivedADRF,which acts throughKATP channels (Löhn
et al., 2002), these experiments were performed in presence of
glibenclamide (5μM) which signiﬁcantly reduced the anticon-
tractile effect of PVAT in WKY (results not shown). However a
signiﬁcant anticontractile effect of PVAT was still maintained as
shown in Figures 1A,B and Table 2. The presence of PVAT signif-
icantly reduced contractions to Ang II only in aortic rings from
WKY. No changes were observed in pD2 values between groups
(Table 2). In SHR, contractions to Ang II were more potent and
effective compared to WKY independently of PVAT (Table 2). No
differences were observed between groups in 75mM KCl-induced
contractions, as previously described (Gálvez et al., 2006).
In the absence of endothelium, contractions to Ang II were sig-
niﬁcantly higher in aortic segments of bothWKYand SHR cleaned
of PVAT (Figures 1C,D; Table 2). The anticontractile effect of
PVAT was lost in endothelium-denuded rings from WKY inde-
pendently of the presence of PVAT (Table 2). No effect of PVAT
was observed in endothelium-independent relaxations to sodium
nitroprusside (SNP, 10−12 to 10−5M; results not shown).
LEPTIN mRNA AND PROTEIN EXPRESSION ARE REDUCED IN
PERIAORTIC ADIPOSE TISSUE FROM SHR
To determine if alterations in leptin production by PVAT might
inﬂuence aortic function we determined leptin levels in PVAT.
Table 1 | Adipose tissue weights in 3-month-old maleWKY and SHR.
WKY SHR
Lumbar adipose tissue (g) 2.1±0.1 1.8±0.1 (p<0.05)
Mesenteric adipose tissue (g) 3.5±0.1 3.1±0.1 (p<0.05)
Periaortic adipose tissue (mg) 207±11 183±15
Data are expressed asmean±SEM.Number of data n=16–18 animals per strain.
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FIGURE 1 | Effect of PVAT on angiotensin II (Ang II)-induced
contractions in aortic rings fromWKY (A) and SHR (B). Effect of
endothelial removal on angiotensin II (Ang II)-induced contractions in aortic
rings from WKY (C) and SHR (D) in presence and absence of PVAT. Data
are expressed in milligram and shown as mean±SEM of 10 animals
per strain.
Table 2 | Effect of PVAT or leptin on Emax and pD2 values of
concentration-response curves to Ang II.
WKY SHR
Emax (mg) pD2 Emax (mg) pD2
−PVAT/+E 497±21 7.3±0.2 598±49# 8.2±0.2#
+PVAT/+E 289±15* 7.4±0.2 502±58# 8.3±0.2#
−PVAT/−E 734±69§ 7.1±0.2 688±39§ 7.9±0.2#
−PVAT/−E 650±53§ 7.3±0.2 642±39§ 7.8±0.2#
−Leptin/+E 411±32 7.2±0.2 640±100# 7.6±0.1#
+Leptin/+E 231±35* 7.2±0.2 582±51# 7.6±0.2#
−Leptin/−E 665±63§ 7.1±0.2 698±52 7.6±0.2#
+Leptin/−E 648±51§ 7.1±0.1 680±32§ 7.7±0.2#
*Signiﬁcant effect of PVAT or leptin (p<0.05): comparison between –PVAT and
+PVAT rings or –leptin and +leptin rings.
#Signiﬁcant effect of strain (p<0.05): comparison between WKY and SHR rings.
§Signiﬁcant effect of endothelium (p<0.05): comparison between +E and −E
rings.
Figure 2 summarizes the results obtained in the analysis of lep-
tin mRNA and protein levels in periaortic AT. Periaortic leptin
levels were signiﬁcantly lower in SHR (p< 0.05) both at mRNA
(Figure 2A) as well as at protein level (Figure 2B).
LEPTIN REDUCES Ang II-INDUCED CONTRACTIONS IN WKY BUT NOT IN
SHR
After preincubation with leptin (10 nM), concentration-response
curves to Ang II (10−10 to 10−6 M) were performed in aortic
FIGURE 2 | Leptin expression and protein levels in periaortic (A,B)
adipose tissue of 3-month-oldWKY and SHR rats. Data are expressed as
mean±SEM of 8–15 determinations per strain. *p<0.05 between groups.
rings of both strains (Figure 3; Table 2). Leptin induced a signiﬁ-
cant reduction of Ang II-induced contractions in rings fromWKY,
whereas the effect of leptin was almost absent in rings from SHR
(Figures 3A,B). The anticontractile effect of leptin was abolished
in endothelium-denuded rings (Figures 3C,D).
VASODILATORY EFFECT OF LEPTIN IS REDUCED IN AORTA OF SHR
Leptin (10−10 to 10−8 M) induced a concentration-dependent
vasodilation in aortic rings from WKY, which was almost abol-
ished in arteries from SHR (Figure 4A). Vasodilatory effect of
leptin was weak reaching a maximal response of 30 and of 5%
of previous contraction in WKY and SHR, respectively. Endothe-
lium removal and incubation with 0.1mM L-NAME completely
abolished relaxation to leptin (results nor shown), suggesting the
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FIGURE 3 | Effect of leptin on angiotensin II (Ang II)-induced
contractions in aortic rings fromWKY (A) and SHR (B). Effect of
endothelial denudation on angiotensin II (Ang II)-induced contractions in
aortic rings from WKY (C) and SHR (D) in absence and presence of
leptin. Data are shown in milligram as mean±SEM of 10 animals
per strain.
FIGURE 4 | Concentration-response curve to leptin (10−10 to 10−8 M)
(A) and acetylcholine (10−9 to 10−4 M) (B) in aortic rings fromWKY and
SHR. Concentration-response curve to Ach in aortic rings from WKY (C) and
SHR (D) in presence and absence of PVAT. Relaxation is expressed as
percentage of a previous contraction to U46619 (10−7 M). Data are shown as
mean±SEM of 10 animals per strain.
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FIGURE 5 | Effect of leptin on endothelial nitric oxide release in response
to acute leptin, assessed by DAF-2 DA staining inWKY (A–C) and in SHR
(D–F). Basal NO release in control rings with endothelium (A,D). Effect of
leptin 10 ng/ml in rings with (B,E) and without (C,F) endothelium. A,
adventitia; M, media; E, endothelium. Arrows indicate the presence of
endothelial cells. Magniﬁcation ×20, zoom ×2. (G) Quantiﬁcation of
endothelial NO production from WKY and SHR animals. Results are
expressed as mean±SEM, n =3 per group.
involvement of NO in this response, as previously observed in rat
aorta (Kimura et al., 2000; Lembo et al., 2000).
The reduced effect of leptin in SHR cannot be attributed to
endothelial dysfunction in this strain since Ach induced a simi-
lar concentration-dependent relaxation (10−9 to 10−4 M) in aorta
from WKY and SHR (Figure 4B). No inﬂuence of PVAT could
be observed in Ach-induced relaxation (Figures 1D and 4C,D),
as previously observed in mesenteric arteries (Gálvez et al., 2006).
Moreover, there were no differences in Ob-Rb receptor expression
between strains (WKY: 1.3 ± 0.1 arbitrary units vs. SHR: 1.2± 0.2
arbitrary units; n.s.)
LEPTIN-INDUCED RELEASE OF NO IS LOWER IN SHR
To support the functional studies, we investigated leptin-induced
NO production in aortic segments by using the ﬂuorescent NO
indicatorDAF2-DA. Inorder to exclude the interactionwith super-
oxide anions, all segments were incubated simultaneously with
SOD (15U/ml). Green ﬂuorescence was negligible in the artery
ring in the presence of L-NAME (results not shown). In aor-
tic rings from WKY, leptin (10 nM) induced a robust increase
in NO production (Figure 5B), when compared to control rings
(Figures 5A,G). The effect of leptin was signiﬁcantly reduced in
aortic rings from SHR (Figures 5D,E,G). NO production was
dependent on the presence of endothelium, since ﬂuorescence was
completely abolished in endothelium-denuded rings from both
strains (Figures 5C,F).
DISCUSSION
This study shows that the anticontractile effect of PVAT is absent
in SHR. Main ﬁndings of this study are that (i) leptin production
is reduced in periaortic AT from SHR and (ii) that vasodilatory
and anticontractile effects of leptin are abolished in SHR aorta.
The diminished vascular effects are due to an impairment of
leptin-mediated NO release from the endothelium. These ﬁnd-
ings suggest that the reduction of leptin production by PVAT may
contribute to increased vascular contractions observed in SHR.
The endothelium-dependent anticontractile effect of PVAT
detected in aortic rings from WKY incubated with Ang II, sug-
gests a paracrine effect of a PVAT-derived factor. Although leptin
antagonists (pegylated leptin inhibitor) have been successfully
used in pig coronary arteries (Payne et al., 2010), they were
unable to block leptin-induced responses in our model, proba-
bly due to species differences (data not shown). As these drugs
are not useful tools to antagonize the anticontractile effect of
PVAT, we chose an indirect approach and we characterized the
effect of exogenous leptin on PVAT-cleaned aortic rings. Leptin
induced a weak concentration-dependent relaxation, which was
endothelium-dependent and linked to NO production, as pre-
viously observed in other studies (Kimura et al., 2000; Lembo
et al., 2000). Moreover, and as observed with PVAT, leptin signif-
icantly reduced Ang II-induced contractions. The anticontractile
effect of leptin was lost in endothelium-denuded rings. Thus, the
effect of leptin fully mimicked the anticontractile effect of PVAT.
However, this coincidence does not allow concluding that leptin
accounts for the anticontractile effect of PVAT and studies car-
ried out with new speciﬁc leptin receptor antagonists would be
necessary to address this question. Otherwise, the participation of
other adipose relaxant factors (Fesüs et al., 2007; Gao et al., 2007;
Lee et al., 2009; Gil-Ortega et al., 2010; Gollasch, 2012) cannot be
excluded, with the exception of ADRF, since all experiments were
performed in presence of glibenclamide (5 μM), an inhibitor of
KATP channels implicated in ADRF-induced aortic vasodilatation
(Löhn et al., 2002; Zeng et al., 2009). In summary, the hypothesis
that leptin might play a pivotal role on the anticontractile effect of
PVAT cannot be demonstrated conclusively with these functional
data.
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A main ﬁnding of this study is that leptin mRNA and pro-
tein expression are lower in PVAT from SHR compared to WKY.
This might be related to the increased sympathetic outﬂow in this
strain (Frohlich and Pfeffer, 1975; Cabassi et al., 2002). Leptin
expression in brown adipocytes depends on AT activity. Condi-
tions associated with activation of brown AT, such as sympathetic
stimulation or cold, decrease leptin gene expression often down
to undetectable levels (Cannon and Nedergaard, 2004). More-
over, adrenergic stimulation via β3-adrenoceptors (Buyse et al.,
2001) is also associated with lower lipid content in the cells, i.e.,
smaller brown adipocytes. Norepinephrine also promotes pro-
liferation of brown preadipocytes and differentiation in mature
brown adipocytes (Cannon and Nedergaard, 2004). Interestingly,
Gao and colleagues have recently suggested that the number of
brown adipocytes in aortic PVAT of SHR is higher than in WKY,
without differences in the amount of PVAT (Lu et al., 2011).We do
not ﬁnd differences either in the amount of periaortic AT between
strains.
The poor vasodilatory/anticontractile effect of leptin detected
in SHR aorta might be due to a reduced NO release from the
endothelium, as shown by DAF2-DA staining. In accordance with
our results, an abrogated effect of leptinhas been reported indiffer-
ent organs from hypertensive animal models (Fortuño et al., 2002;
Wold et al., 2002; Villarreal et al., 2006; Rodriguez et al., 2007).
This effect cannot be attributed to endothelial dysfunction, since
relaxation to Ach was similar between strains. This latter obser-
vation is in agreement with previous reports showing that young
SHR (12 weeks of age) and some SHR strains are particularly
resistant to end organ damage, maintaining normal endothelial
function despite the hypertension (Gschwend et al., 2002). More-
over, it has to be noted that all experiments were performed in the
presence of indomethacin to exclude participation of vasocon-
strictor prostanoids, which is the main mechanism of endothelial
dysfunction in aorta from SHR (Lüscher and Vanhoutte, 1986).
The anticontractile effect of PVAT on Ang II-induced contrac-
tionswas also abolished in SHR.A similar effect has been described
for phenylephrine-induced contractions correlating with a lower
ADRF release (Zeng et al., 2009) or Ang 1–7 release (Lu et al.,
2011). Consequently, we propose that the different anticontractile
effect of PVAT between strains might be attributed to two aspects:
(i) PVAT-derived leptin is signiﬁcantly lower in SHR and (ii) leptin
has almost no effect on endothelial NO release in SHR, probably
due to an impaired activation of eNOS.
A question of additional interest concerns the partial contribu-
tion of circulating and PVAT-derived leptin to the regulation of
vascular tone, which would be linked to the role of leptin either as
an endocrine and/or as a paracrine/autocrine mediator involved
in regulating arterial function.We might reason that differences in
plasma leptin concentration between strains, although statistically
signiﬁcant, would not account for relevant differences in leptin
receptor occupancy. In fact, theKD of leptin for leptin receptors has
been estimated between 0.4 and 0.7 nmol/l (Da Silva et al., 1998).
Inour experimentalmodel plasma leptin ranges between7.6 ng/ml
(approximately 0.47 nM) and 11.5 ng/ml (approximately 0.72 nM)
inWKYand SHR, respectively. Thus, it can be estimated that leptin
receptor occupancy is close to 50% in both strains. Nevertheless, a
role for circulating leptin cannot be excluded, since at this receptor
occupancy the vasodilatory effect of leptin between 0.1 and 1 nM
is signiﬁcantly reduced both in aorta and mesenteric arteries from
SHR (Gálvez et al., 2006).
In conclusion, this study shows that PVAT-derived leptin might
contribute, together with other relaxant factors, to the net anti-
contractile effect of PVAT. This effect is abolished in aorta from
SHR probably due to both a reduced leptin mRNA and protein
expression in PVAT and to an impairment of leptin-mediated
NO release from the endothelium. We suggest that PVAT is a
tissue with high plasticity, responding to different physiological
and physiopathological situations through phenotypic changes in
either tissue amount, morphology, or in the balance of vasoactive
factors.
ACKNOWLEDGMENTS
This work was supported by grants from Ministerio de Edu-
cación y Ciencia (SAF 2009-09714, SAF2008-02703), Grupos
UCM GR-921641, Fundación Universitaria San Pablo-CEU, Fun-
dación Mutua Madrileña, and SESCAMET.Ana I. de las Heras and
Marta Gil-Ortega are fellows from MEC. Concha F. García-Prieto
is a fellow from CEU-Universidad San Pablo.
REFERENCES
Arribas, S. M., Daly, C. J., Gonzalez,
M. C., and McGrath, J. C. (2007).
Imaging the vascular wall using con-
focal microscopy. J. Physiol. 584,
5–9.
Buyse, M., Viengchareun, S., Bado, A.,
and Lombes, M. (2001). Insulin and
glucocorticoids differentially regu-
late leptin transcription and secre-
tion in brown adipocytes. FASEB J.
15, 1357–1366.
Cabassi, A., Vinci, S., Cantoni, A. M.,
Quartieri, F., Moschini, L., Cavazz-
ini, S., Cavatorta, A., and Borghetti,
A. (2002). Sympathetic activation in
adipose tissue and skeletal muscle of
hypertensive rats. Hypertension 36,
656–661.
Cannon, B., and Nedergaard, J.
(2004). Brown adipose tis-
sue: function and physiological
signiﬁcance. Physiol. Rev. 84,
277–359.
Cano,V., Ezquerra, L.,Ramos,M. P., and
Ruiz-Gayo,M. (2003). Regulation of
leptin distribution between plasma
and cerebrospinal ﬂuid by cholecys-
tokinin receptors. Br. J. Pharmacol.
140, 647–652.
Da Silva, B. A., Bjorbaek, C. S., and
Flier, J. S. (1998). Functional prop-
erties of leptin receptor isoforms
containing the Gln-Pro extracellular
domain mutation of the fatty rat.
Endocrinology 139, 3681–3690.
Dashwood, M. R., Dooley, A., Shi-Wen,
X., Abraham, D. J., Dreifaldt, M.,
and Souza, D. S. (2011). Perivascu-
lar fat-derived leptin: a potential role
in improved vein graft performance
in coronary artery bypass surgery.
Interact. Cardiovasc. Thorac. Surg.
12, 170–173.
Dubrovska, G., Verlohren, S., Luft, F.
C., and Gollasch, M. (2004). Mecha-
nisms of ADRF release from rat aor-
tic adventitial adipose tissue. Am. J.
Physiol. 286, 1107–1113.
Elias, C. F., Lee, C., Kelly, J., Aschke-
nasi, C., Ahima, R. S., Couceyro, P.
R., Kuhar, M. J., Saper, C. B., and
Elmquist, J. K. (1998). Leptin acti-
vates hypothalamic CART neurons
projecting to the spinal cord. Neuron
21, 1375–1385.
Fesüs,G.,Dubrovska,G.,Gorzelniak,K.,
Kluge, R., Huang, Y., Luft, F. C., and
Gollasch, M. (2007). Adiponectin is
a novel humoral vasodilator. Cardio-
vasc. Res. 75, 719–727.
Fortuño, A., Rodriguez, A., Gomez-
Ambrosi, J., Muñiz, P., Salvador, J.,
Diez, J., and Frühbeck, G. (2002).
Leptin inhibits angiotensin II-indu-
ced intracellular calcium increase
and vasoconstriction in rat aorta.
Endocrinology 143, 3555–3560.
www.frontiersin.org June 2012 | Volume 3 | Article 103 | 7
Gálvez-Prieto et al. Hypertension and perivascular adipose tissue
Frohlich,E.D., andPfeffer,M.A. (1975).
Adrenergic mechanisms in human
hypertension and in spontaneously
hypertensive rats. Clin. Sci. Mol.
Med. Suppl. 2, 225s–238s.
Frühbeck, G. (1999). Pivotal role of
nitric oxide in the control of blood
pressure after leptin administration.
Diabetes 48, 903–908.
Gálvez, B., de Castro, J., Herold,
D., Dubrovska, G., Arribas, S.,
González, M. C., Aranguez, I., Luft,
F. C., Ramos, M. P., Gollasch,
M., and Fernández-Alfonso, M. S.
(2006). Perivascular adipose tissue
and mesenteric vascular function
in spontaneously hypertensive rats.
Arterioscler. Thromb. Vasc. Biol. 58,
989–994.
Gálvez-Prieto, B., Bolbrinker, J., Stucchi,
P., de Las Heras, A. I., Merino, B.,
Arribas, S., Ruiz-Gayo, M., Huber,
M., Wehland, M., Kreutz, R., and
Fernandez-Alfonso, M. S. (2008).
Comparative expression analysis
of the renin-angiotensin system
components between white and
brown perivascular adipose tissue. J.
Endocrinol. 197, 55–64.
Gao, Y. J. (2007). Dual modulation
of vascular function by perivascular
adipose tissue and its potential cor-
relation with adiposity/lipoatrophy-
related vascular dysfunction. Curr.
Pharm. Des. 13, 2185–2192.
Gao, Y. J., Holloway, A. C., Zeng, Z. H.,
Lim, G. E., Petrik, J. J., Foster, W.
G., and Lee, R. M. (2005). Prenatal
exposure to nicotine causes postna-
tal obesity and altered perivascular
adipose tissue function. Obes. Res.
13, 687–692.
Gao,Y. J., Lu,C., Su, L.Y., Sharma,A. M.,
and Lee, R. M. (2007). Modulation
of vascular function by perivascular
adipose tissue: the role of endothe-
lium and hydrogen peroxide. Br. J.
Pharmacol. 151, 323–331.
Gao, Y. J., Takemori, K., Su, L. Y., An, W.
S., Lu, C., Sharma, A. M., and Lee, R.
M. (2006). Perivascular adipose tis-
sue promotes vasoconstriction: the
role of superoxide anion.Cardiovasc.
Res. 71, 363–373.
Gil-Ortega, M., Somoza, B., Aranguez,
I., Ruiz-Gayo, M., and Fernández-
Alfonso, M. S. (2009). Changes
in resistance artery function dur-
ing the development of diet-
induced obesity. Hypertension 54,
E105–E106.
Gil-Ortega, M., Stucchi, P., Guzmán-
Ruiz, R., Cano, V., Arribas, S.,
González, M. C., Ruiz-Gayo, M.,
Fernández-Alfonso, M. S., and
Somoza, B. (2010). Adaptative nitric
oxide overproduction in perivascu-
lar adipose tissue during early diet-
induced obesity. Endocrinology 151,
3299–3306.
Gollasch, M. (2012). Vasodilator signals
from perivascular adipose tissue. Br.
J. Pharmacol. 165, 633–642.
Gollasch,M., andDubrovska,G. (2004).
Paracrine role for periadventitial
adipose tissue in the regulation of
arterial tone. Trends Pharmacol. Sci.
25, 647–653.
Gschwend, S., Pinto-Sietsma, S. J.,
Buikema, H., Pinto, Y. M., van Gilst,
W. H., Schulz, A., de Zeeuw, D., and
Kreutz, R. (2002). Impaired coro-
nary endothelial function in a rat
model of spontaneous albuminuria.
Kidney Int. 62, 181–191.
Hall, J. E., Brands, M. W., Hildebrandt,
D. A., Kuo, J., and Fitzgerald, S.
(2000). Role of sympathetic nervous
system and neuropeptides in obesity
hypertension. Braz. J. Med. Biol. Res.
33, 605–618.
Kimura,K., Tsuda,K., Baba,A., Kawabe,
T., Boh-oka, S., Ibata, M., Mori-
waki, C., Hano, T., and Nishio, I.
(2000). Involvement of nitric oxide
in endothelium-dependent arterial
relaxation by leptin. Biochem. Bio-
phys. Res. Commun. 273, 745–749.
Knudson, J. D., Payne, G. A., Borbouse,
L., and Tune, J. D. (2008). Lep-
tin and mechanisms of endothe-
lial dysfunction and cardiovascular
disease. Curr. Hypertens. Rep. 10,
434–439.
Lee, R. M., Lu, C., Su, L. Y., and Gao, Y.
J. (2009). Endothelium-dependent
relaxation factor released by perivas-
cular adipose tissue. J. Hypertens. 27,
782–790.
Lembo, G., Vecchione, C., Fratta, L.,
Marino, G., Trimarco, V., d’Amati,
G., and Trimarco, B. (2000). Lep-
tin induces direct vasodilatation
through distinct endothelial mech-
anisms. Diabetes 49, 293–297.
Löhn, M., Dubrovska, G., Lauterbach,
B., Luft, F. C., Gollasch, M., and
Sharma, A. M. (2002). Periadventi-
tial fat releases a vascular relaxing
factor. FASEB J. 16, 1057–1063.
Lu, C., Su, L. Y., Lee, R. M., and Gao, Y.
J. (2011). Alterations in perivascular
adipose tissue structure and func-
tion in hypertension.Eur. J. Pharma-
col. 656, 68–73.
Lüscher, T. F., and Vanhoutte, P.
M. (1986). Endothelium-dependent
contractions to acetylcholine in the
aorta of the spontaneously hyper-
tensive rat. Hypertension 8, 344–348.
Momin, A. U., Melikian, N., Shah, A.
M., Grieve, D. J., Wjeatcroft, S. B.,
John, L., EI Gamel, A., Desai, J. B.,
Nelson, T., Driver, C., Sherwood, R.
A., and Kearney, M. T. (2006). Lep-
tin is an endothelial-independent
vasodilator in humans with coro-
nary artery disease: evidence for tis-
sue speciﬁcity of leptin resistance.
Eur. Heart J. 27, 2294–2299.
Payne, G. A., Borbouse, L., Kumar, S.,
Neeb, Z., Alloosh, M., Sturek, M.,
and Tune, J. D. (2010). Epicardial
perivascular adipose-derived lep-
tin exacerbates coronary endothelial
dysfunction in metabolic syndrome
via a protein kinase C-beta pathway.
Arterioscler. Thromb. Vasc. Biol. 30,
1711–1717.
Rodriguez, A., Fortuño, A., Gomez-
Ambrosi, J., Zalba, G., Diez, J., and
Frühbeck, G. (2007). The inhibitory
effect of leptin on angiotensin II-
induced vasoconstriction in vascular
smoothmuscle cells ismediated via a
nitric oxide-dependent mechanism.
Endocrinology 148, 324–331.
Rodríguez, A., Gómez-Ambrosi, J.,
Catalán, V., Fortuño, A., and Früh-
beck, G. (2010). Leptin inhibits
the proliferation of vascular smooth
muscle cells induced by angiotensin
II through nitric oxide-dependent
mechanisms. Mediators Inﬂamm.
2010, 105489.
Sahin, A. S., Bariskaner, H., Gökbel,
H., and Okudan, N. (2009). The
dual effects of leptin on aortic rings
with and without endothelium iso-
lated from streptozotocin-induced
diabetic rats. Methods Find. Exp.
Clin. Pharmacol. 31, 325–329.
Schwartz, M. W., Peskind, E., Raskind,
M., Boyko, E. J., and Porte, D.
(1996). Cerebrospinal ﬂuid leptin
levels: plasma levels and adiposity in
humans. Nat. Med. 2, 589–593.
Somoza, B., González, M. C., González,
J. M., Abderrahim, F., Arribas, S.
M., and Fernández-Alfonso, M. S.
(2005). Modulatory role of the
adventitia on noradrenaline and
angiotensin II responses role of
endothelium and AT2 receptors.
Cardiovasc. Res. 65, 478–486.
Somoza, B., Guzmán, R., Cano, V.,
Merino, B., Ramos, P., Díez-
Fernández, C., Fernández-Alfonso,
M. S., and Ruiz-Gayo, M. (2007).
Induction of cardiac uncoupling
protein-2 expression and adeno-
sine 5′-monophosphate-activated
protein kinase phosphorylation
during early states of diet-induced
obesity in mice. Endocrinology 148,
924–931.
Vecchione, C., Maffei, A., Colella, S.,
Aretini, A., Poulet, R., Fratta, L.,
Trimarco, V., Trimarco, B., and
Lembo, G. (2002). Leptin effect on
endothelial nitric oxide is mediated
throughAkt-endothelial nitric oxide
synthase phosphorylation pathway.
Diabetes 51, 168–173.
Verlohren, S., Dubrovska, G., Tsang, S.
Y.,Essin,K.,Luft,F.C.,Huang,Y., and
Gollasch, M. (2004). Visceral peri-
adventitial adipose tissue regulates
arterial tone of mesenteric arteries.
Hypertension 44, 271–276.
Villarreal, D., Reams, G., Freeman, R.,
Spear, R., Tchoukina, I., and Samar,
H. (2006). Leptin blockade atten-
uates sodium excretion in saline-
loaded normotensive rats. Mol. Cell.
Biochem. 283, 153–157.
Wold, L. E., Relling, D. P., Duan, J.,
Norby, F. L., and Ren, J. (2002).
Abrogated leptin-induced cardiac
contractile response in ventricular
myocytes under spontaneous hyper-
tension. Role of JAK/STAT pathway.
Hypertension 39, 69–74.
Zeng,Z.H.,Zhang,Z.H., Luo,B.H.,He,
W. K., Liang, L. Y., He, C. C., and Su,
C. J. (2009). The functional changes
of the perivascular adipose tissue in
spontaneously hypertensive rats and
the effects of atorvastatin therapy.
Clin. Exp. Hypertens. 31, 355–363.
Zhang, Y., Proenca, R., Maffei, M.,
Barone, M., Leopold, L., and Fried-
man, J. (1994). Positional cloning of
the mouse obese gene and its human
homologue. Nature 372, 425–432.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 02 March 2012; paper pend-
ing published: 27 March 2012; accepted:
10 May 2012; published online: 05 June
2012.
Citation: Gálvez-Prieto B, Somoza
B, Gil-Ortega M, García-Prieto CF,
de las Heras AI, González MC, Arribas S,
Aranguez I, Bolbrinker J, Kreutz R, Ruiz-
Gayo M and Fernández-Alfonso MS
(2012) Anticontractile effect of perivascu-
lar adipose tissue and leptin are reduced
in hypertension. Front. Pharmacol.
3:103. doi: 10.3389/fphar.2012.00103
This article was submitted to Frontiers
in Cardiovascular and Smooth Muscle
Pharmacology, a specialty of Frontiers in
Pharmacology.
Copyright © 2012 Gálvez-Prieto,
Somoza, Gil-Ortega, García-Prieto,
de las Heras, González, Arribas,
Aranguez, Bolbrinker, Kreutz, Ruiz-
Gayo and Fernández-Alfonso. This is
an open-access article distributed under
the terms of the Creative Commons
Attribution Non Commercial License,
which permits non-commercial use,
distribution, and reproduction in other
forums, provided the original authors
and source are credited.
Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology June 2012 | Volume 3 | Article 103 | 8
